These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7160985)

  • 21. [Guidelines for the empirical antibiotic treatment of intraabdominal infections].
    Tellado JM; Sitges-Serra A; Barcenilla F; Palomar M; Serrano R; Barberán J; Moya M; Martínez M; García-Rodríguez JA; Mensa J; Prieto J
    Rev Esp Quimioter; 2005 Jun; 18(2):179-86. PubMed ID: 16130041
    [No Abstract]   [Full Text] [Related]  

  • 22. Microbiology of intraabdominal infection and contamination.
    Condon RE
    Eur J Surg Suppl; 1996; (576):9-12. PubMed ID: 8908461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cefoperazone in infections of the abdomen and soft parts].
    Chlebusch-von der Heyden R
    Med Welt; 1982 Jan; 33(2):73-5. PubMed ID: 6460149
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of anaerobic bacteria in human infections.
    Zambrano D
    Clin Ther; 1993; 15(2):244-60; discussion 215. PubMed ID: 8519035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
    Polk HC; Fink MP; Laverdiere M; Wilson SE; Garber GE; Barie PS; Hebert JC; Cheadle WG
    Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
    Lin WJ; Lo WT; Chu CC; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):249-54. PubMed ID: 16783457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of bacterial burden in wounds.
    Stotts NA
    Adv Wound Care; 1995; 8(4):suppl 46-52. PubMed ID: 7627404
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    Wilson SE; Faulkner K
    Am Surg; 1998 May; 64(5):402-7. PubMed ID: 9585772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of polymicrobial intra-abdominal, pelvic, and diabetic foot infections.
    Zervos M
    Compr Ther; 1998; 24(6-7):295-301. PubMed ID: 9669093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
    Aldridge KE
    Eur J Surg Suppl; 1994; (573):31-7. PubMed ID: 7524793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection.
    Hopkins JA; Lee JC; Wilson SE
    Am Surg; 1993 Dec; 59(12):791-6. PubMed ID: 8256930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
    Madan AK
    Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruptured staphylococcal splenic abscess resulting in peritonitis: report of a case.
    Balasubramanian SP; Mojjada PR; Bose SM
    Surg Today; 2002; 32(6):566-7. PubMed ID: 12107789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacteriological samples from wounds].
    Fromantin I; Kriegel I; Cuzon F
    Soins; 2009 Jun; (736):28, 30-2. PubMed ID: 19670677
    [No Abstract]   [Full Text] [Related]  

  • 40. Open management of the abdomen and planned reoperations in severe bacterial peritonitis.
    Bosscha K; Hulstaert PF; Visser MR; van Vroonhoven TJ; van der Werken C
    Eur J Surg; 2000 Jan; 166(1):44-9. PubMed ID: 10688216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.